Novel mRNA blood test can show which heart failure patients will benefit from ICD MTBeurope A novel blood test for changes in messenger RNA that predict sudden death risk in heart failure patients is set to help physicians decide which patients would benefit from an implantable cardioverter defibrillator (ICD). The findings were presented at ... |
